Cargando…

Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey

PURPOSE: The purpose of this study was to determine the fertility rates following treatment by means of the BEACOPP regimen (regular and escalated) (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) as compared to the ABVD regimen (doxorubicin, vinblastine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Boltežar, Lučka, Pintarić, Karlo, Jezeršek Novaković, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785158/
https://www.ncbi.nlm.nih.gov/pubmed/26678493
http://dx.doi.org/10.1007/s10815-015-0636-6
_version_ 1782420355137142784
author Boltežar, Lučka
Pintarić, Karlo
Jezeršek Novaković, Barbara
author_facet Boltežar, Lučka
Pintarić, Karlo
Jezeršek Novaković, Barbara
author_sort Boltežar, Lučka
collection PubMed
description PURPOSE: The purpose of this study was to determine the fertility rates following treatment by means of the BEACOPP regimen (regular and escalated) (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) as compared to the ABVD regimen (doxorubicin, vinblastine, dacarbazine, bleomycin) in Hodgkin lymphoma patients under the age of 40 at the time of treatment. METHODS: A questionnaire was sent to 180 Hodgkin lymphoma (HL) patients. The questionnaire was composed of questions concerning reproduction and also menopausal and aging symptoms in females and males. The analyses were made using data collected from 123 patients (76 females and 47 males) who returned the questionnaire. All of the patients were treated between 1999 and 2012. RESULTS: In comparing the ABVD and BEACOPP groups of female patients, the frequency of the therapy-induced amenorrhea and the restored menses following treatment were found to be significantly different statistically (p = 0.002 and p = 0.012, respectively). The secondary amenorrhea statistically appeared more often in the BEACOPP group (p = 0.003) while the cases of achieving pregnancy and having children after chemotherapy were not significantly different (p = 0.630, p = 0.070, respectively). In comparing the ABVD and BEACOPP treatments in male patients, the only significant difference was in the number of artificially inseminated or in vitro pregnancies achieved in the BEACOPP and escalated BEACOPP group, p = 0.008 and p = 0.002, respectively. In total, 45.2 % of patients in the ABVD female group, 34.6 % in the BEACOPP female group, 52.6 % in the ABVD male group, and 33.3 % in the male BEACOPP group, respectively, of patients attempting conception post-therapy, had children after chemotherapy. CONCLUSIONS: Based on these high rates of childbirth following BEACOPP chemotherapy, we have concluded that intensified chemotherapy is not a definite predictor of reduced fertility in young HL patients.
format Online
Article
Text
id pubmed-4785158
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-47851582016-04-09 Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey Boltežar, Lučka Pintarić, Karlo Jezeršek Novaković, Barbara J Assist Reprod Genet Fertility Preservation PURPOSE: The purpose of this study was to determine the fertility rates following treatment by means of the BEACOPP regimen (regular and escalated) (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) as compared to the ABVD regimen (doxorubicin, vinblastine, dacarbazine, bleomycin) in Hodgkin lymphoma patients under the age of 40 at the time of treatment. METHODS: A questionnaire was sent to 180 Hodgkin lymphoma (HL) patients. The questionnaire was composed of questions concerning reproduction and also menopausal and aging symptoms in females and males. The analyses were made using data collected from 123 patients (76 females and 47 males) who returned the questionnaire. All of the patients were treated between 1999 and 2012. RESULTS: In comparing the ABVD and BEACOPP groups of female patients, the frequency of the therapy-induced amenorrhea and the restored menses following treatment were found to be significantly different statistically (p = 0.002 and p = 0.012, respectively). The secondary amenorrhea statistically appeared more often in the BEACOPP group (p = 0.003) while the cases of achieving pregnancy and having children after chemotherapy were not significantly different (p = 0.630, p = 0.070, respectively). In comparing the ABVD and BEACOPP treatments in male patients, the only significant difference was in the number of artificially inseminated or in vitro pregnancies achieved in the BEACOPP and escalated BEACOPP group, p = 0.008 and p = 0.002, respectively. In total, 45.2 % of patients in the ABVD female group, 34.6 % in the BEACOPP female group, 52.6 % in the ABVD male group, and 33.3 % in the male BEACOPP group, respectively, of patients attempting conception post-therapy, had children after chemotherapy. CONCLUSIONS: Based on these high rates of childbirth following BEACOPP chemotherapy, we have concluded that intensified chemotherapy is not a definite predictor of reduced fertility in young HL patients. Springer US 2015-12-17 2016-03 /pmc/articles/PMC4785158/ /pubmed/26678493 http://dx.doi.org/10.1007/s10815-015-0636-6 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Fertility Preservation
Boltežar, Lučka
Pintarić, Karlo
Jezeršek Novaković, Barbara
Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
title Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
title_full Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
title_fullStr Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
title_full_unstemmed Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
title_short Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
title_sort fertility in young patients following treatment for hodgkin’s lymphoma: a single center survey
topic Fertility Preservation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785158/
https://www.ncbi.nlm.nih.gov/pubmed/26678493
http://dx.doi.org/10.1007/s10815-015-0636-6
work_keys_str_mv AT boltezarlucka fertilityinyoungpatientsfollowingtreatmentforhodgkinslymphomaasinglecentersurvey
AT pintarickarlo fertilityinyoungpatientsfollowingtreatmentforhodgkinslymphomaasinglecentersurvey
AT jezerseknovakovicbarbara fertilityinyoungpatientsfollowingtreatmentforhodgkinslymphomaasinglecentersurvey